Found 2031 results for "cancer"
For anyone who has undergone chemotherapy, radiation, or inflammatory bowel disease flares, the gut's ability to regenerate its lining is not an abstract…
For the roughly 80,000 Americans diagnosed with kidney cancer each year, surgery remains the primary treatment — yet a significant proportion face recurrence…
Sarcopenia management is converging on a multi-modal clinical framework, with protein thresholds of 1.2–1.5 g/kg/day, β-hydroxy-β-methylbutyrate (HMB), and…
Breast cancer patients using GLP-1 receptor agonists (GLP-1RAs) achieve meaningful but measurably smaller weight reductions than those seen in landmark…
For the millions of patients diagnosed with colorectal cancer annually — a disease notorious for its resistance to conventional immunotherapy — identifying…
Cell membrane architecture may be far more druggable than previously assumed. Lipid rafts — highly ordered microdomains in the plasma membrane — govern how…
One of oncology's most frustrating paradoxes has been the near-undruggability of c-Myc — a transcription factor implicated in the vast majority of human…
Pancreatic ductal adenocarcinoma remains one of the deadliest malignancies precisely because its dominant driver mutation — KRAS — has historically been…
Understanding how large biological molecules cross cell membranes without being destroyed has been one of the most persistent puzzles in drug delivery and…
For decades, a silent compromise has shaped breast cancer research: the most common form of the disease — estrogen receptor-positive (ER+) breast cancer — has…
Something measurable in younger generations' biology may be aging faster than the calendar suggests — and that gap between chronological and biological age…
For the roughly 50% of colorectal cancer patients who develop liver metastases, chemotherapy is a lifeline — but the liver damage it causes may simultaneously…
For the roughly 15,000 Americans diagnosed annually with smoldering multiple myeloma, the critical question is not whether they have cancer but when — or…
Cancer immunotherapy's most stubborn obstacle isn't recognizing tumors — it's keeping immune cells functional long enough to destroy them. When…
For patients facing glioblastoma — one of oncology's most treatment-resistant cancers — understanding why immune therapies consistently fail is no longer just…
For the roughly 75,000 Americans diagnosed with kidney cancer annually, treatment options for the most common subtype — clear cell renal cell carcinoma — have…
For the millions of cancer patients who relapse after treatment, the culprit is increasingly traced not to the bulk tumor but to a resilient subpopulation of…
Copper is one of biology's most paradoxical minerals — essential in trace amounts yet lethal when it accumulates in the wrong cellular compartment. A…
Understanding exactly how lipid signaling molecules commandeer cellular machinery has profound implications for drug design targeting inflammation, pain…
Castration-resistant prostate cancer represents one of the most lethal clinical endpoints in oncology, affecting tens of thousands of men annually who have…